NCR1 and cancer: As leptin-treated NK-92 cells also showed a significantly less cytotoxicity against CRC cells than untreated NK-92 cells, it was discussed that a reduced expression of the activating NKp46 may be associated with an impaired NK cell response against tumor cells, thus increasing the risk to develop cancer (53).